Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation

Phase 2

Completed

Conditions: Liver Transplantation
Bone Resorption
Heart Transplantation

Interventions: Drug: Zoledronic acid
Drug: Alendronate
Other: Placebo Alendronate
Other: Placebo Zoledronic Acid

First Posted Date: 2006-03-01

Last Posted Date: 2018-08-16

Lead Sponsor: Columbia University

Target Recruit Count: 111

Registration Number: NCT00297830

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

A Pilot Study of Neurocysticercosis Treatment

Phase 3

Completed

Conditions: Neurocysticercosis

Interventions: Other: placebo
Drug: albendazole

First Posted Date: 2006-01-30

Last Posted Date: 2010-02-08

Lead Sponsor: Columbia University

Target Recruit Count: 178

Registration Number: NCT00283699

Locations: 🇪🇨
Vicente Corral Moscoso Hospital of Cuenca, Centro de Epilepsia, Facultad de Ciencias Médicinas de la Universidad de Cuenca IDIUC (Área 5), Av. 12 de Abril. Cdla., Cuenca, Ecuador
🇪🇨
Teodoro Maldonado Carbo Hospital, Av. 25 de Julio Vía Puerto Marítimo, Guayaquil, Ecuador
🇪🇨
Baca Ortiz Children's Hospital, Av. Colon s/n y 6 de Diciembre, Quito, Ecuador

and more 2 locations

Randomized Trial of Telemedicine for Diabetes Care

Not Applicable

Completed

Conditions: Diabetes Mellitus

First Posted Date: 2006-01-04

Last Posted Date: 2023-09-18

Lead Sponsor: Columbia University

Target Recruit Count: 1665

Registration Number: NCT00271739

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
SUNY Upstate Medical University, Syracuse, New York, United States

Leptin in Human Energy and Neuroendocrine Homeostasis

Not Applicable

Terminated

Conditions: Obesity
Weight Loss

Interventions: Drug: Subcutaneous Placebo
Drug: Leptin

First Posted Date: 2005-12-15

Last Posted Date: 2019-09-18

Lead Sponsor: Columbia University

Target Recruit Count: 22

Registration Number: NCT00265980

Locations: 🇺🇸
Columbia University, New York, New York, United States

Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)

Phase 1

Completed

Conditions: Stroke

Interventions: Drug: lovastatin

First Posted Date: 2005-10-25

Last Posted Date: 2016-05-09

Lead Sponsor: Columbia University

Target Recruit Count: 33

Registration Number: NCT00243880

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Clinical Trial of High Dose CoQ10 in ALS

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis
Lou Gehrig's Disease

Interventions: Drug: Placebo
Drug: coenzyme Q10

First Posted Date: 2005-10-25

Last Posted Date: 2024-05-07

Lead Sponsor: Columbia University

Target Recruit Count: 185

Registration Number: NCT00243932

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Department of Neurology, Little Rock, Arkansas, United States
🇺🇸
California Pacific Medical Center, San Francisco, California, United States
🇺🇸
University of California at San Francisco, San Francisco, California, United States

and more 16 locations

Coronary Heart Disease Incidence: Depression & Inflammation Risk

Completed

Conditions: Heart Diseases
Depression
Cardiovascular Diseases
Coronary Disease
Inflammation

First Posted Date: 2005-10-19

Last Posted Date: 2016-02-05

Lead Sponsor: Columbia University

Target Recruit Count: 3227

Registration Number: NCT00241774

Locations: 🇺🇸
Columbia University, New York, New York, United States

Screen and Treat for Cervical Cancer Prevention

Phase 3

Terminated

Conditions: Cervical Cancer

First Posted Date: 2005-10-06

Last Posted Date: 2015-07-09

Lead Sponsor: Columbia University

Target Recruit Count: 7123

Registration Number: NCT00233727

Locations: 🇿🇦
University of Cape Town, Cape Town, Western Cape, South Africa

Anesthesia and Postoperative Pain

Phase 4

Completed

Conditions: Postoperative Pain

Interventions: Drug: Nicotine (drug)

First Posted Date: 2005-10-05

Last Posted Date: 2024-07-12

Lead Sponsor: Columbia University

Target Recruit Count: 23

Registration Number: NCT00232817

Locations: 🇺🇸
New York Presbyterian Hospital, New York, New York, United States

Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia

Phase 4

Completed

Conditions: Focal Dystonia

Interventions: Drug: Botulinum toxin, type B

First Posted Date: 2005-09-21

Last Posted Date: 2014-05-09

Lead Sponsor: Columbia University

Target Recruit Count: 16

Registration Number: NCT00208091

Locations: 🇺🇸
Neurological Institute, 710 W. 168th Street, NI-1112, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy